NEFL and Brain atrophy: As clinically relevant primary endpoints, we assessed infarct size and brain atrophy using magnetic resonance imaging (MRI), neurofilament light (NF-L) release in the plasma as a biomarker of neurodegeneration, and the overall effect on recovery using a horizontal ladder test and a nest building test.